<DOC>
	<DOCNO>NCT00223054</DOCNO>
	<brief_summary>In study researcher want investigate genetic polymorphism cytochrome 450 enzyme multiple drug resistance ( MDR ) gene renal transplant patient look difference dose immunosuppressive drug ( tacrolimus , sirolimus , everolimus , cyclosporine A ) . All patient receive one drug include drug blood trough level , dose genetics compare .</brief_summary>
	<brief_title>Polymorphism Cytochrome P450-system Renal Transplants</brief_title>
	<detailed_description>Primary endpoint 1. serum creatinine patient without polymorphysms 2. rate rejection patient without polymorphysms</detailed_description>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Renal transplant patient receive one follow drug : tacrolimus sirolimus everolimus cyclosporin A fluvastatin Informed consent give patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>cyclosporin A</keyword>
	<keyword>Tacrolimus</keyword>
	<keyword>Everolimus</keyword>
	<keyword>Sirolimus</keyword>
	<keyword>Fluvastatin</keyword>
</DOC>